Global Medical Imaging Agents Market, By Isotope (Technetium, Thallium, Gallium, Iodine, Samarium, Rhenium, Flurodeoxy Glucose, Gallium, Rubidium, Others), Modality (X-Ray/CT, MRI, Ultrasound, SPECT, PET), Application (Cardiology, Cancer, Gastrointestinal, Musculoskeletal, Neurology, Nephrology, Obstetrics and Gynecology, Pulmonary, Hepatology And Others), End Users (Hospitals and Clinics, Diagnostic Centers, Academic Institutes and Research Organizations), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Medical Imaging Agents Market
Global medical imaging agents market size is expected to grow at a compound annual rate of 2.97% in the forecast period 2021 to 2028 and is likely to reach USD 12,539.32 million by 2028. The rise in the product acceptance and usage is the factor responsible for the growth of medical imaging agents market in the forecast period of 2021 to 2028.
Medical imaging agents are the chemical substances which basically enables doctors to visualize the function of the specific internal organs, tissues or vessel during analysis or medical procedures. The imaging aids in revealing internal hidden picture and is used widely used by doctors for diagnosing arthritis in joints, bone loss, calcification and bone fractures among others.
The prevalence of chronic disorders such as cardiovascular diseases and cancer is expected to heighten the overall demand for medical imaging agents market over the forecast period of 2021 to 2028. Moreover, the favorable government initiatives and preventive healthcare and disease screening programs also drive the market’s overall growth. However, the high cost associated with procedures and equipment and the dearth of skilled professionals is projected to act as a restraint towards the growth of the market.
The new innovative product development which aids in disclosing more details is estimated to further generate new opportunities for the medical imaging agents market in the forecast period. On the other hand, the side effects of diagnostic imaging procedure may be a major threat for the growth of the market within the forecast period.
This medical imaging agents market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Global Medical imaging agents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Medical Imaging Agents Market Scope and Market Size
Medical imaging agents market is segmented on the basis of isotope, modality, application, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- Based on isotope, the market is bifurcated into technetium, thallium, gallium, iodine, samarium, rhenium, flurodeoxy glucose, gallium, rubidium, others.
- On the basis of modality, the medical imaging agents market has been segmented into X-Ray/CT, MRI, Ultrasound, SPECT and PET.
- On the basis of application, the medical imaging agents market is segmented into cardiology, cancer, gastrointestinal, musculoskeletal, neurology, nephrology, obstetrics and gynecology, pulmonary, hepatology and others. Others have further been segmented into neck, bone and salivary gland imaging.
- Based on end user, the market is segmented into hospitals and clinics, diagnostic centers, academic institutes and research organizations.
Medical Imaging Agents Market Country Level Analysis
Medical imaging agents market is analyses and market size, volume information is provided by isotope, modality, application, and end user as referenced above.
The countries covered in the medical imaging agents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is estimated to lead the medical imaging agents market due to the technological development and availability of well-established healthcare facilities within this region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 due to rising population.
The country section of the global medical imaging agents market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data
Healthcare Infrastructure growth Installed base and New Technology Penetration
Medical imaging agents market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for medical imaging agents market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the medical imaging agents market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Global Medical Imaging Agents Market Share Analysis
Medical imaging agents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to medical imaging agents market.
The major players covered in the medical imaging agents report are Aytu BioPharma, Inc., Bayer AG, Bracco Diagnostic Inc., Daiichi Sankyo Company Limited, Eli Lilly and Company., Guerbet, Lantheus Medical Imaging, Inc., Carestream Health., FONAR Corp., Hitachi Healthcare Americas, Shimadzu Corporation, Koninklijke Philips N.V., FUJIFILM Holdings Corporation, Canon India Pvt Ltd., Hovione , Barco, Samsung Medison Co. Ltd, ESAOTE SPA, DAI HAN PHARM CO.,LTD., FutureChem Co., Drägerwerk AG & Co. KGaA, Ltd, and Graton Pharma among other domestic and global players. Market share data is available for Global, North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.